263.11
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Factset Research Systems Inc stock is traded at $263.11, with a volume of 909.05K.
It is up +6.47% in the last 24 hours and up +9.10% over the past month.
FactSet provides financial data and portfolio analytics to the global investment community. The company aggregates data from third-party data suppliers, news sources, exchanges, brokerages, and contributors into its workstations. In addition, it provides essential portfolio analytics that companies use to monitor portfolios and address reporting requirements. Buy-side clients (including wealth and corporate clients) account for over 80% of FactSet's annual subscription value. In 2015, the company acquired Portware, a provider of trade execution software. In 2017, it acquired BISAM, a risk management and performance measurement provider. In 2022, it completed its purchase of CUSIP Global Services.
See More
Previous Close:
$247.11
Open:
$252.81
24h Volume:
909.05K
Relative Volume:
0.96
Market Cap:
$9.36B
Revenue:
$2.40B
Net Income/Loss:
$587.79M
P/E Ratio:
16.92
EPS:
15.5461
Net Cash Flow:
$682.87M
1W Performance:
+4.33%
1M Performance:
+9.10%
6M Performance:
-9.82%
1Y Performance:
-41.03%
Factset Research Systems Inc Stock (FDS) Company Profile
Name
Factset Research Systems Inc
Sector
Phone
(203) 810-1000
Address
45 GLOVER AVENUE, NORWALK, CT
Compare FDS vs SPGI, CME, MCO, ICE, NDAQ
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
FDS
Factset Research Systems Inc
|
263.11 | 8.79B | 2.40B | 587.79M | 682.87M | 15.55 |
|
SPGI
S P Global Inc
|
437.84 | 127.43B | 15.73B | 5.15B | 5.56B | 15.81 |
|
CME
Cme Group Inc
|
245.10 | 86.82B | 6.76B | 4.26B | 4.33B | 11.72 |
|
MCO
Moodys Corp
|
495.72 | 85.12B | 7.87B | 2.50B | 2.75B | 13.95 |
|
ICE
Intercontinental Exchange Inc
|
137.67 | 76.49B | 12.93B | 3.99B | 4.24B | 6.8684 |
|
NDAQ
Nasdaq Inc
|
89.21 | 49.81B | 8.27B | 1.91B | 2.00B | 3.3193 |
Factset Research Systems Inc Stock (FDS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-17-26 | Resumed | BofA Securities | Underperform |
| Dec-17-25 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Sep-22-25 | Upgrade | UBS | Neutral → Buy |
| Sep-12-25 | Upgrade | Rothschild & Co Redburn | Sell → Neutral |
| Jun-26-25 | Upgrade | Raymond James | Underperform → Mkt Perform |
| Mar-21-25 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Oct-09-24 | Downgrade | Redburn Atlantic | Neutral → Sell |
| Oct-02-24 | Initiated | Evercore ISI | In-line |
| Aug-13-24 | Initiated | Wells Fargo | Equal Weight |
| May-30-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Apr-11-24 | Initiated | Wolfe Research | Underperform |
| Mar-22-24 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-08-23 | Downgrade | Deutsche Bank | Buy → Hold |
| Aug-25-23 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jun-15-23 | Resumed | BofA Securities | Neutral |
| May-15-23 | Initiated | BMO Capital Markets | Market Perform |
| May-09-23 | Initiated | Wells Fargo | Equal Weight |
| Mar-28-23 | Upgrade | Redburn | Sell → Neutral |
| Jan-12-23 | Upgrade | Credit Suisse | Neutral → Outperform |
| Aug-26-22 | Upgrade | Deutsche Bank | Hold → Buy |
| May-17-22 | Initiated | Redburn | Sell |
| Mar-30-22 | Initiated | Deutsche Bank | Hold |
| Dec-14-21 | Upgrade | Northcoast | Sell → Neutral |
| Sep-30-21 | Upgrade | UBS | Sell → Neutral |
| Aug-25-21 | Upgrade | Barclays | Equal Weight → Overweight |
| Jul-08-21 | Initiated | RBC Capital Mkts | Outperform |
| Jun-11-20 | Downgrade | Northcoast | Neutral → Sell |
| Jun-01-20 | Resumed | Oppenheimer | Perform |
| Nov-22-19 | Initiated | Jefferies | Hold |
| Sep-27-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jul-16-19 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jun-27-19 | Downgrade | Goldman | Neutral → Sell |
| Dec-07-18 | Upgrade | Barclays | Underweight → Equal Weight |
| Dec-07-18 | Resumed | Credit Suisse | Neutral |
| Dec-05-17 | Downgrade | Northcoast | Buy → Neutral |
| Nov-08-17 | Initiated | Goldman | Neutral |
| Sep-21-17 | Upgrade | Northcoast | Neutral → Buy |
| Jan-10-17 | Downgrade | Barclays | Equal Weight → Underweight |
| Sep-27-16 | Downgrade | Raymond James | Mkt Perform → Underperform |
| Aug-26-16 | Initiated | Macquarie | Neutral |
| Jul-12-16 | Initiated | Credit Suisse | Outperform |
| Mar-22-16 | Initiated | Sterne Agee CRT | Neutral |
| Mar-16-16 | Downgrade | Stifel | Buy → Hold |
| Mar-10-16 | Downgrade | UBS | Neutral → Sell |
| Dec-08-15 | Reiterated | Stifel | Buy |
| Nov-10-15 | Initiated | Cantor Fitzgerald | Hold |
View All
Factset Research Systems Inc Stock (FDS) Latest News
FactSet Research Systems Inc (FDS) Shares Surge 6.5% -- What GF Score of 80 Tells Investors - GuruFocus
Rockwell Automation, Inc. Stock 12‑Month Price Target Raised to $477.52, Implies 1% Upside - TradingView
Regal Rexnord Corporation Stock 12‑Month Price Target Raised to $260, Implies 21% Upside - TradingView
Ralliant Corporation Stock 12‑Month Price Target Raised to $69.8, Implies 1% Upside - TradingView
Corning Incorporated Stock 12‑Month Price Target Raised to $217.38, Implies 14% Upside - TradingView
Western Digital Corporation Stock 12‑Month Price Target Raised to $634.22, Implies 9% Upside - TradingView
Interactive Brokers Group, Inc. Stock 12‑Month Price Target Raised to $101.45, Implies 8% Upside - TradingView
CDW Corporation Stock 12‑Month Price Target Raised to $147.56, Implies 2% Upside - TradingView
FactSet Research Systems Inc.'s Stock Price Skyrockets to $263.11, Marking a Stellar 6.47% Increase - Smartkarma
FactSet Research Systems Inc. stock outperforms competitors on strong trading day - MarketWatch
Krystal Biotech, Inc. Stock 12‑Month Price Target Raised to $369.44, Implies 1% Upside - TradingView
West Pharmaceutical Services, Inc. Stock 12‑Month Price Target Raised to $383.93, Implies 9% Upside - TradingView
KT Corporation Stock 12‑Month Price Target Cut to $24.49, Implies 36% Upside - TradingView
Avantor, Inc. Stock 12‑Month Price Target Raised to $10.31, Implies 1% Downside - TradingView
10x Genomics, Inc. Stock 12‑Month Price Target Raised to $35.46, Implies 17% Downside - TradingView
Fortrea Holdings Inc. Stock 12‑Month Price Target Raised to $17.8 - TradingView
Tencent Holdings Ltd Stock 12‑Month Price Target Cut to HKD 688.24, Implies 50% Upside - TradingView
Revvity, Inc. Stock 12‑Month Price Target Raised to $116.07, Implies 3% Upside - TradingView
Mettler-Toledo International, Inc. Stock 12‑Month Price Target Raised to $1348.91, Implies 4% Upside - TradingView
Mirion Technologies, Inc. Stock 12‑Month Price Target Cut to $27.4, Implies 61% Upside - TradingView
Ameren Corporation Stock 12‑Month Price Target Cut to $122.14, Implies 8% Upside - TradingView
Papa John's International, Inc. Stock 12‑Month Price Target Cut to $37.36, Implies 12% Upside - TradingView
Fortrea Holdings Inc. Stock 12‑Month Price Target Raised to $17.4, Implies 2% Downside - TradingView
Bruker Corporation Stock 12‑Month Price Target Raised to $58.08, Implies 3% Downside - TradingView
Are Wall Street analysts predicting FactSet Research Systems stock will climb or sink? - MSN
MSC Industrial Direct Company, Inc. Stock 12‑Month Price Target Raised to $133.67, Implies 9% Upside - TradingView
Circle Internet Group, Inc. Stock 12‑Month Price Target Cut to $127.54, Implies 93% Upside - TradingView
Fastenal Company Stock 12‑Month Price Target Raised to $48.33, Implies 4% Upside - TradingView
Here's what to expect from FactSet Research's next earnings report - MSN
Fortune Brands Innovations, Inc. Stock 12‑Month Price Target Raised to $51, Implies 1% Downside - TradingView
FactSet Research stock holds steady as analysts watch growth - ad-hoc-news.de
Virgin Galactic Holdings, Inc. Stock 12‑Month Price Target Raised to $3.54, Implies 38% Upside - TradingView
Argan, Inc. Stock 12‑Month Price Target Cut to $679.8, Implies 8% Upside - TradingView
Samsung Electronics Co., Ltd. Stock 12‑Month Price Target Raised to KRW 504597.71, Implies 77% Upside - TradingView
Nurix Therapeutics, Inc. Stock 12‑Month Price Target Raised to $32.5, Implies 32% Upside - TradingView
Healthpeak Properties, Inc. Stock 12‑Month Price Target Raised to $21.68 - TradingView
Tokyo Electron Ltd. Stock 12‑Month Price Target Raised to JPY 73354.55, Implies 3% Upside - TradingView
Virtu Financial, Inc. Stock 12‑Month Price Target Raised to $60.43, Implies 10% Downside - TradingView
Miami International Holdings, Inc. Stock 12‑Month Price Target Raised to $51.4, Implies 20% Upside - TradingView
Black Hills Corporation Stock 12‑Month Price Target Raised to $85.2, Implies 16% Upside - TradingView
Tradeweb Markets Inc. Stock 12‑Month Price Target Cut to $130, Implies 34% Upside - TradingView
Keurig Dr Pepper Inc. Stock 12‑Month Price Target Raised to $34.47, Implies 12% Upside - TradingView
Robinhood Markets, Inc. Stock 12‑Month Price Target Raised to $120.59, Implies 5% Upside - TradingView
Gemini Space Station, Inc. Stock 12‑Month Price Target Cut to $6.5, Implies 53% Upside - TradingView
CME Group Inc. Stock 12‑Month Price Target Cut to $285.93, Implies 19% Upside - TradingView
PepsiCo, Inc. Stock 12‑Month Price Target Cut to $156.84, Implies 14% Upside - TradingView
Melco Resorts & Entertainment Limited Stock 12‑Month Price Target Raised to $8.44, Implies 60% Upside - TradingView
LEXX Q3'26 Earnings: revenue estimate is 0 USD - TradingView
MCBS Q2'26 Earnings: revenue estimate is 52.40M USD - TradingView
ISBA Q2'26 Earnings: revenue estimate is 23.00M USD - TradingView
ALV Q2'26 Earnings: revenue estimate is 2.77B USD - TradingView
Factset Research Systems Inc Stock (FDS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):